Quality of Extemporaneously Compounded Nitroglycerin Ointment
Authors:
- Daniel L. AzarnoffDADaniel L. Azarnoff
- J. C. LeeJLJ. C. Lee
- Charles LeeCLCharles Lee
- John ChandlerJCJohn Chandler
- David KarlinDKDavid Karlin
- 1 April 2007
- journal article
- Published by Wolters Kluwer Health in Diseases of the Colon & Rectum
- Vol. 50 (4) , 509-516
Abstract
Published clinical trials support the use of 0.2 to 0.4 percent nitroglycerin ointment for the treatment of an anal fissure, although no product is yet available in the United States. In 2004, 84,000 prescriptions were written for compounded nitroglycerin ointment. This study was designed to evaluate the quality of extemporaneously compounded nitroglycerin ointment. Prescriptions for 0.3 percent nitroglycerin ointment were filled at retail pharmacies and shipped to analytical laboratory for analysis by their validated method. Five of 24 (20.8 percent) samples did not meet the United States Pharmacopoeia requirement for content uniformity of 90 to 110 percent and< 6 percent relative standard deviation. Seven of 24 samples (29.2 percent) were subpotent based on the United States Pharmacopoeia requirement of 90 to 115 percent of label claim, and 1 sample was suprapotent. When considered for potency and/or content uniformity, 11 of 24 (45.8 percent) were misbranded and poor quality. Forty-six percent of the nitroglycerin ointment products compounded by 24 pharmacies did not meet the United States Pharmacopoeia specifications for potency and/or content uniformity when filling a prescription for 0.3 percent nitroglycerin ointment. These results raise significant issues regarding whether patients are put at undue risk relative to the relief of anal fissure pain. The pain associated with chronic anal fissure is severe, often debilitating, and may affect the patient's ability to work.Keywords
This publication has 6 references indexed in Scilit:
- Concepts in Pathogenesis and Treatment of Chronic Anal Fissure—A Review of The LiteratureAmerican Journal of Gastroenterology, 2003
- Botulinum Toxin as Second-Line Therapy for Chronic Anal Fissure Failing 0.2 Percent Glyceryl TrinitrateDiseases of the Colon & Rectum, 2003
- American Gastroenterological Association medical position statement: Diagnosis and care of patients with anal fissure, This document presents the official recommendations of the American Gastroenterological Association (AGA) on Anal Fissures. It was approved by the Clinical Practice Committee on May 19, 2002 and by the AGA Governing Board on July 27, 2002.Gastroenterology, 2003
- A randomized trial of glyceryl trinitrate ointment and nitroglycerin patch in healing of anal fissuresInternational Journal of Colorectal Disease, 2000
- Glyceryl trinitrate ointment for the treatment of chronic anal fissureDiseases of the Colon & Rectum, 1999
- A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissureThe Lancet, 1997